You are here

Clinical Trials

OCA Meets Primary Endpoint of Improvement in Liver Fibrosis
Treatment Improves Motor Function, Preserves Neurons
Possible One-Time Treatment for Rare Pediatric CLN2 Disease
Key Finding Shows 65% of Patients Diagnosed With Early-Stage Lung Cancer
Drug Could Treat Cognitive Dysfunction and Other Symptoms
“EsophaCap” Uses Genetic Biomarkers to Detect Dangerous Changes in the Cells Lining the Esophagus
Approximately 40% of Patients With BRAF-Mutated Biliary Tract Cancer Respond Well
iPSC Therapy Designed to Salvage Eye, Prevent Vision Loss
Relief for Patients With Life-Threatening Blood-Clotting Disorder
Study Demonstrates Rapid Response in Patients, and Doesn’t Affect Tamoxifen Efficacy
Empagliflozin Could Help Prevent Heart Disease and Heart Failure
Daily Use of AHCC Supplement Could Support Immune System, Eliminate HPV
High-Tech “Nightwatch” is Capable of Detecting 85 Percent of Severe Night-Time Epileptic Seizures
Combination of Buprenorphine and Samidorphan Targets Opioid System Safely and Effectively
REDUCE-IT Study Shows 25% Risk Reduction in CV Events with Vascepa
Two Phase 3 Studies Met Endpoint of Complete Clearance of Lesions
Claims that tramiprosate helps stabilize patients over an 18-month period.
Latest failure brings amyloid hypothesis into question

Pages